Methods used to develop the CT scan contrast agent injection protocols

 

The development of these CT scanning protocols took place gradually over a 4 year period from 1995 to 1999. During this time, the scanning protocols evolved through numerous changes.  The current protocols are the "I series", and they were preceded by series A,B,C,D,E,F,G and H.

The A protocols were the starting point. They divided patients into subjective small, medium and large groups.
The B protocols used specific weight ranges for the small, medium and large groups.
The C protocols divided the weight categories into 5 groups, and introduced different injection rates for each group. The transition from A to B to C protocols occurred quickly, during the first two months.

The D protocols added minor improvements.  These protocols were studied in a "qualitative" study, comparing subjective scan quality of the D series CT images compared to CT images from fixed doses of 100ml and 120ml. The results showed overall better quality images from the D series compared to fixed doses.

The E, F, G and H protocols were studied "quantitatively".  The types of data collected were:

  1. Liver "enhancement" is the post-contrast CT density, in Hounsfield units,  measured on a mid-liver slice, by tracing a Region-Of-Interest (ROI) on the liver parenchyma. (The computer software automatically calculated the mean density of all pixels within the ROI).  The ROI avoided major intra-hepatic blood vessels and biliary ducts.  The studies did not include pre-contrast scans,  so it was not possible to subtract pre-contrast from post-contrast images.
  2. Intra-hepatic portal venous enhancement was scored on the following scale:  0= hypodense portal veins,  1=portal veins isodense with liver parenchyma,  2= portal veins mildly brighter than liver parenchyma.  3=portal veins moderately brighter than liver parenchyma,  4=portal veins were so bright as to appear completely white.
  3. Hepatic venous enhancement was scored on a similar scale:  0=hypodense hepatic veins, 1=hepatic veins isodense with liver parenchyma, 2= hepatic veins mildly brighter than liver parenchyma, 3=hepatic veins moderately brighter than liver parenchyma, 4=hepatic veins were so bright as to appear competely white.
  4. Kidney parenchymal enhancement was scored on the following scale:  0=thin cortex enhancement only, 1=mix of cortical and partial medulla enhancement, 2=equal cortex and medulla enhancement, 3= medulla has hyperdense streaks from excreted contrast in the pyramids,  4=opacified urine is visible in the renal pelvis.

The E and F protocols used a 60ml dose for the weight group 38-47 kilograms.  This was changed to 70ml in the G and H protocols.  ( The 60ml dose in this weight group resulted in a mean liver enhancement of 106.0 Hounsfield units, and the 70ml dose in this weight group resulted in a mean liver enhancement of 117.4 Hounsfield units, which is closer to the means of the other weight groups.)

The G protocol added a new weight category for patients weighing > 117 kilograms and changed their dose to 160ml from 140ml. (However, there was hardly any difference: the mean liver enhancement changed from 101.6 to 103.8 Hounsfield units.)

The G protocols shifted the scan Delays earlier, in order to accumulate data from earlier delay times, especially in lighter patients.

The H protocols were developed when scan slice thickness changed from 10mm to 8mm thick.  All the delays were adjusted.

The Current I protocols were designed after analysing all data from previous series. The Delays were adjusted slightly to their optimum values.

Below, is a record of the parameters used in the E,F,G & H protocols. The Rates haven't changed, and are not shown.

  E
Delays
Abd
E
Delays
Chest
E
Chest
Abd
    F
Delays
Abd
F
Delays
Chest
F
Chest
Abd
    G
Delays
Abd
G
Delays
Chest
G
Chest
Abd
    H
Delays
Abd
H
Delays
Chest
H
Chest
Abd
                    160ml 66 53 41   160ml 66 57 38
140ml 74 57 29   140ml 69 57 29   140ml 66 53 41   140ml 66 56 38
120ml 71 56 27   120ml 68 56 27   120ml 65 52 40   120ml 65 55 37
100ml 69 55 26   100ml 67 55 26   100ml 64 51 39   100ml 62 53 35
80ml 66 54 24   80ml 66 54 24   80ml 63 51 38   80ml 60 51 34
60ml 62 54 22   60ml 64 54 22   70ml 63 51 38   70ml 59 51 33
50ml 58 53 20   50ml 60 53 20   60ml 62 50 38   60ml 58 50 32

There are some pit-falls in the methods, but they were not bad.

back to CT scan weight based protocol index

End of page Navigation links: Halls.md home  or  Back to top    

Copyright © 1999 - present.  Steven B. Halls, MD   .   1-780-608-9141   .   [email protected]